COMPANY

Celdara Medical

HQ: Lebanon, NH source · celdaramedical.com ↗ · New England

Location: Lebanon, NH · source · Oct 15, 2026

Profile checked Oct 10, 2026

50NIH grants

Funding and NIH signals

NIH award NIH awarded $356K (SBIR Phase I 1R43DK143897-01A1, new, notice Aug 28, 2026); 6 NIH awards totaling $2.5M in the last 12 months. NIH RePORTER 1R43DK143897-01A1 (Aug 28, 2026)
Evidence (6 events)
- Aug 28, 2026 · NIH RePORTER 1R43DK143897-01A1
  Organization: CELDARA MEDICAL, LLC; City/State: LEBANON, NH; Project number: 1R43DK143897-01A1; Activity code: R43; Fiscal year: 2026; Award notice date: 2026-08-28; FY total cost (award amount): 356328; Administering IC: National Institute of Diabetes and Digestive and Kidney Diseases; Project title: Development of a Novel, Allogeneic Cell Therapy for Difficult to Treat IBD; Organization type: Domestic For-Profits
- Aug 24, 2026 · NIH RePORTER 1R43AI197698-01
  Organization: CELDARA MEDICAL, LLC; City/State: LEBANON, NH; Project number: 1R43AI197698-01; Activity code: R43; Fiscal year: 2026; Award notice date: 2026-08-24; FY total cost (award amount): 320863; Administering IC: National Institute of Allergy and Infectious Diseases; Project title: Precision CAR-NK therapy for VK4-1 autoreactive B cells in autoimmune diseases: advancing treatment with preserved immune function.; Organization type: Domestic For-Profits
- Aug 21, 2026 · NIH RePORTER 1R43AI192073-01A1
  Organization: CELDARA MEDICAL, LLC; City/State: LEBANON, NH; Project number: 1R43AI192073-01A1; Activity code: R43; Fiscal year: 2026; Award notice date: 2026-08-21; FY total cost (award amount): 320863; Administering IC: National Institute of Allergy and Infectious Diseases; Project title: Development of an immunotherapeutic agent for treatment of osteomyelitis; Organization type: Domestic For-Profits
- Jun 25, 2026 · NIH RePORTER 5R25AG078135-05
  Organization: CELDARA MEDICAL, LLC; City/State: LEBANON, NH; Project number: 5R25AG078135-05; Activity code: R25; Fiscal year: 2026; Award notice date: 2026-06-25; FY total cost (award amount): 162000; Administering IC: National Institute on Aging; Project title: Alzheimer's-focused Celdara Medical High-Potential Entrepreneurial Fellowship Program (A-CHEF); Organization type: Domestic For-Profits
- Jun 16, 2026 · NIH RePORTER 1R43TR006062-01A1
  Organization: CELDARA MEDICAL, LLC; City/State: LEBANON, NH; Project number: 1R43TR006062-01A1; Activity code: R43; Fiscal year: 2026; Award notice date: 2026-06-16; FY total cost (award amount): 310564; Administering IC: National Center for Advancing Translational Sciences; Project title: Engineered Tregs as a therapy to Gaucher syndrome; Organization type: Domestic For-Profits
- May 26, 2026 · NIH RePORTER 5R44CA298512-02
  Organization: CELDARA MEDICAL, LLC; City/State: LEBANON, NH; Project number: 5R44CA298512-02; Activity code: R44; Fiscal year: 2026; Award notice date: 2026-05-26; FY total cost (award amount): 1024401; Administering IC: National Cancer Institute; Project title: Development of CM-HZ01 as a non-alpha-IL2 therapeutic for the treatment of metastatic melanoma; Organization type: Domestic For-Profits

Job counts as of Oct 18, 2026. All funding and NIH signals

Timeline

Aug 28, 2026 Grant Government grant — SBIR: $356,328 (annual award, as published), announced Aug 28, 2026. Agency: NIH/NIDDK. Source: government award database. source ↗
Aug 24, 2026 Grant Government grant — SBIR: $320,863 (annual award, as published), announced Aug 24, 2026. Agency: NIH/NIAID. Source: government award database. source ↗
Aug 21, 2026 Grant Government grant — SBIR: $320,863 (annual award, as published), announced Aug 21, 2026. Agency: NIH/NIAID. Source: government award database. source ↗
Jun 25, 2026 Grant Government grant — NIH R25: $162,000 (annual award, as published), announced Jun 25, 2026. Agency: NIH/NIA. Source: government award database. source ↗
Jun 16, 2026 Grant Government grant — SBIR: $310,564 (annual award, as published), announced Jun 16, 2026. Agency: NIH/NCATS. Source: government award database. source ↗
May 26, 2026 Grant Government grant — SBIR: $1.02M (annual award, as published), announced May 26, 2026. Agency: NIH/NCI. Source: government award database. source ↗
Aug 18, 2025 Grant Government grant — NIH R25: $162,000 (annual award, as published), announced Aug 18, 2025. Agency: NIH/NIA. Source: government award database. source ↗
Aug 5, 2025 Grant Government grant — SBIR: $921,394 (annual award, as published), announced Aug 5, 2025. Agency: NIH/NINDS. Source: government award database. source ↗
Jun 12, 2025 Grant Government grant — SBIR: $421,106 (annual award, as published), announced Jun 12, 2025. Agency: NIH/NINDS. Source: government award database. source ↗
Mar 11, 2025 Grant Government grant — STTR: $955,865 (annual award, as published), announced Mar 11, 2025. Agency: NIH/NIAID. Source: government award database. source ↗
Dec 24, 2024 Grant Government grant — SBIR: $1.23M (annual award, as published), announced Dec 24, 2024. Agency: NIH/NCI. Source: government award database. source ↗

Funding

Last 2 years.

Aug 28, 2026 Government grant — SBIR: $356,328 (annual award, as published), announced Aug 28, 2026. Agency: NIH/NIDDK. Source: government award database. source ↗
Aug 24, 2026 Government grant — SBIR: $320,863 (annual award, as published), announced Aug 24, 2026. Agency: NIH/NIAID. Source: government award database. source ↗
Aug 21, 2026 Government grant — SBIR: $320,863 (annual award, as published), announced Aug 21, 2026. Agency: NIH/NIAID. Source: government award database. source ↗
Jun 25, 2026 Government grant — NIH R25: $162,000 (annual award, as published), announced Jun 25, 2026. Agency: NIH/NIA. Source: government award database. source ↗
Jun 16, 2026 Government grant — SBIR: $310,564 (annual award, as published), announced Jun 16, 2026. Agency: NIH/NCATS. Source: government award database. source ↗
May 26, 2026 Government grant — SBIR: $1.02M (annual award, as published), announced May 26, 2026. Agency: NIH/NCI. Source: government award database. source ↗
Aug 18, 2025 Government grant — NIH R25: $162,000 (annual award, as published), announced Aug 18, 2025. Agency: NIH/NIA. Source: government award database. source ↗
Aug 5, 2025 Government grant — SBIR: $921,394 (annual award, as published), announced Aug 5, 2025. Agency: NIH/NINDS. Source: government award database. source ↗
Jun 12, 2025 Government grant — SBIR: $421,106 (annual award, as published), announced Jun 12, 2025. Agency: NIH/NINDS. Source: government award database. source ↗
Mar 11, 2025 Government grant — STTR: $955,865 (annual award, as published), announced Mar 11, 2025. Agency: NIH/NIAID. Source: government award database. source ↗
Dec 24, 2024 Government grant — SBIR: $1.23M (annual award, as published), announced Dec 24, 2024. Agency: NIH/NCI. Source: government award database. source ↗

NIH awards 50

Annual award amounts. Total $45.3M.

Aug 30, 2024 NIH award 4R44NS132666-02 FY2024: $921,486 awarded for that fiscal year; activity R44 (SBIR); PI MURAD, JOANA M; recipient as written: CELDARA MEDICAL, LLC, LEBANON, NH. Development of CM-CS1 CAR Treg to Treat Amyotr source ↗
Aug 8, 2024 NIH award 5R25AG078135-03 FY2024: $162,000 awarded for that fiscal year; activity R25 (OTHER_NIH); PI COLEMAN, JULIE H; recipient as written: CELDARA MEDICAL, LLC, LEBANON, NH. Alzheimer's-focused Celdara Medical Hig source ↗
Jul 31, 2024 NIH award 5R44DK135154-03 FY2024: $999,828 awarded for that fiscal year; activity R44 (SBIR); PI MURAD, JOANA M; recipient as written: CELDARA MEDICAL, LLC, LEBANON, NH. Anti-hIAPP for the preservation of pancreatic source ↗
May 16, 2024 NIH award 5R44AI157074-03 FY2024: $998,375 awarded for that fiscal year; activity R44 (SBIR); PI COOPER, COLLEEN DOYLE; recipient as written: CELDARA MEDICAL, LLC, LEBANON, NH. Development of CM-IAV1 for Treatment of source ↗
Feb 22, 2024 NIH award 5R42AI132047-04 FY2024: $993,938 awarded for that fiscal year; activity R42 (STTR); PI MURAD, JOANA M; recipient as written: CELDARA MEDICAL, LLC, LEBANON, NH. A human monoclonal antibody therapy for treatm source ↗
Sep 19, 2023 NIH award 1R43NS127620-01A1 FY2023: $231,974 awarded for that fiscal year; activity R43 (SBIR); PI COLEMAN, JULIE H; recipient as written: CELDARA MEDICAL, LLC, LEBANON, NH. Kv2.1-Targeted First in Class Neuroprotect source ↗
Sep 18, 2023 NIH award 1R44NS132666-01 FY2023: $466,950 awarded for that fiscal year; activity R44 (SBIR); PI MURAD, JOANA M; recipient as written: CELDARA MEDICAL, LLC, LEBANON, NH. Development of CM-CS1 CAR Treg to Treat Amyotr source ↗
Sep 8, 2023 NIH award 4R44DK135154-02 FY2023: $999,432 awarded for that fiscal year; activity R44 (SBIR); PI MURAD, JOANA M; recipient as written: CELDARA MEDICAL, LLC, LEBANON, NH. Anti-hIAPP for the preservation of pancreatic source ↗
Aug 9, 2023 NIH award 5R44CA265424-03 FY2023: $769,404 awarded for that fiscal year; activity R44 (SBIR); PI MURAD, JOANA M; recipient as written: CELDARA MEDICAL, LLC, LEBANON, NH. Preclinical development of CM-CX1 for the trea source ↗
Jun 14, 2023 NIH award 5R25AG078135-02 FY2023: $162,000 awarded for that fiscal year; activity R25 (OTHER_NIH); PI COLEMAN, JULIE H; recipient as written: CELDARA MEDICAL, LLC, LEBANON, NH. Alzheimer's-focused Celdara Medical Hig source ↗
Jun 12, 2023 NIH award 4R44AI157074-02 FY2023: $999,635 awarded for that fiscal year; activity R44 (SBIR); PI COOPER, COLLEEN DOYLE; recipient as written: CELDARA MEDICAL, LLC, LEBANON, NH. Preclinical development of an important source ↗
Mar 1, 2023 NIH award 2R42AI132047-03 FY2023: $1,000,000 awarded for that fiscal year; activity R42 (STTR); PI MURAD, JOANA M; recipient as written: CELDARA MEDICAL, LLC, LEBANON, NH. A human monoclonal antibody therapy for trea source ↗
Sep 22, 2022 NIH award 1R44DK135154-01 FY2022: $299,896 awarded for that fiscal year; activity R44 (SBIR); PI MURAD, JOANA M; recipient as written: CELDARA MEDICAL, LLC, LEBANON, NH. Anti-hIAPP for the preservation of pancreatic source ↗
Sep 1, 2022 NIH award 4R44CA265424-02 FY2022: $712,718 awarded for that fiscal year; activity R44 (SBIR); PI MURAD, JOANA M; recipient as written: CELDARA MEDICAL, LLC, LEBANON, NH. Preclinical development of CM-CX1 for the trea source ↗
Aug 9, 2022 NIH award 1R43HL162238-01A1 FY2022: $300,590 awarded for that fiscal year; activity R43 (SBIR); PI COOPER, COLLEEN DOYLE; recipient as written: CELDARA MEDICAL, LLC, LEBANON, NH. Development of a broad spectrum antim source ↗
Aug 1, 2022 NIH award 1R25AG078135-01 FY2022: $162,000 awarded for that fiscal year; activity R25 (OTHER_NIH); PI COLEMAN, JULIE H; recipient as written: CELDARA MEDICAL, LLC, LEBANON, NH. Alzheimer's-focused Celdara Medical Hig source ↗
Jul 25, 2022 NIH award 1R43CA271880-01A1 FY2022: $368,052 awarded for that fiscal year; activity R43 (SBIR); PI MURAD, JOANA M; recipient as written: CELDARA MEDICAL, LLC, LEBANON, NH. CAR T platform to treat solid tumors source ↗
Apr 25, 2022 NIH award 1R44AI157074-01A1 FY2022: $300,000 awarded for that fiscal year; activity R44 (SBIR); PI COOPER, COLLEEN DOYLE; recipient as written: CELDARA MEDICAL, LLC, LEBANON, NH. Development of CM-IAV1 for Treatment source ↗
Feb 14, 2022 NIH award 5R44AI136273-05 FY2022: $974,351 awarded for that fiscal year; activity R44 (SBIR); PI REDER, JAKE; recipient as written: CELDARA MEDICAL, LLC, LEBANON, NH. Development of CM-SV1, a monoclonal antibody trea source ↗
Dec 9, 2021 NIH award 5R41AI157527-02 FY2022: $290,738 awarded for that fiscal year; activity R41 (STTR); PI MURAD, JOANA M; recipient as written: CELDARA MEDICAL, LLC, LEBANON, NH. A Novel Broad-spectrum Antiviral Agent source ↗
Sep 8, 2021 NIH award 1R44CA265424-01 FY2021: $274,085 awarded for that fiscal year; activity R44 (SBIR); PI MURAD, JOANA M; recipient as written: CELDARA MEDICAL, LLC, LEBANON, NH. Preclinical development of CM-CX1 for the trea source ↗
Jul 20, 2021 NIH award 5R44DK117714-03 FY2021: $747,225 awarded for that fiscal year; activity R44 (SBIR); PI REDER, JAKE; recipient as written: CELDARA MEDICAL, LLC, LEBANON, NH. Mitigation of Acute Kidney Injury (AKI) using the source ↗
Mar 1, 2021 NIH award 5R44AI136273-04 FY2021: $984,986 awarded for that fiscal year; activity R44 (SBIR); PI GUYRE, PAUL; recipient as written: CELDARA MEDICAL, LLC, LEBANON, NH. Development of CM-SV1, a monoclonal antibody trea source ↗
Dec 31, 2020 NIH award 1R41AI157527-01 FY2021: $299,916 awarded for that fiscal year; activity R41 (STTR); PI MURAD, JOANA M; recipient as written: CELDARA MEDICAL, LLC, LEBANON, NH. A Novel Broad-spectrum Antiviral Agent source ↗
Sep 11, 2020 NIH award 1R43DK125161-01A1 FY2020: $299,152 awarded for that fiscal year; activity R43 (SBIR); PI GUYRE, PAUL; recipient as written: CELDARA MEDICAL, LLC, LEBANON, NH. Biomarker of IAPP dysfunction in prediabetes an source ↗
Sep 8, 2020 NIH award 5UT2GM130176-03 FY2020: $1,451,724 awarded for that fiscal year; activity UT2 (STTR); PI REDER, JAKE; recipient as written: CELDARA MEDICAL, LLC, LEBANON, NH. DRIVEN: Accelerating Medical Entrepreneurship i source ↗
Aug 14, 2020 NIH award 5R44AR073067-03 FY2020: $730,718 awarded for that fiscal year; activity R44 (SBIR); PI MURAD, JOANA M; recipient as written: CELDARA MEDICAL, LLC, LEBANON, NH. Cellular Immunotherapy for Systemic Sclerosis source ↗
Jul 24, 2020 NIH award 4R44DK117714-02 FY2020: $998,624 awarded for that fiscal year; activity R44 (SBIR); PI HOUSER, BRANDY LYNN; recipient as written: CELDARA MEDICAL, LLC, LEBANON, NH. Mitigation of Acute Kidney Injury (AKI) u source ↗
Apr 15, 2020 NIH award 1R41AI147902-01A1 FY2020: $258,360 awarded for that fiscal year; activity R41 (STTR); PI HOUSER, BRANDY LYNN; recipient as written: CELDARA MEDICAL, LLC, LEBANON, NH. Autonomous RNA-Mediated Anti-Influenza source ↗
Mar 24, 2020 NIH award 4R44AI136273-03 FY2020: $962,825 awarded for that fiscal year; activity R44 (SBIR); PI GUYRE, PAUL; recipient as written: CELDARA MEDICAL, LLC, LEBANON, NH. Development of CM-SV1, a monoclonal antibody trea source ↗